BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28324108)

  • 1. Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol.
    Streeten EA; Mohtasebi Y; Konig M; Davidoff L; Ryan K
    J Clin Endocrinol Metab; 2017 May; 102(5):1505-1510. PubMed ID: 28324108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From hypocalcemia to hypercalcemia-an unusual clinical presentation of a patient with permanent postsurgical hypoparathyroidism.
    Sundaresh V; Levine SN
    J Clin Endocrinol Metab; 2015 Jan; 100(1):21-4. PubMed ID: 25303492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
    Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
    Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcemia-induced renal insufficiency during therapy with dihydrotachysterol.
    Jehle DR; Keller F; Schwarz A; Jehle PM
    J Med; 1999; 30(1-2):39-50. PubMed ID: 10515239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Hypoparathyroidism Treatment on the Kidney in Children: Long-Term Retrospective Follow-Up Study.
    Levy I; Licht C; Daneman A; Sochett E; Harrington J
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4106-13. PubMed ID: 26323021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hypercalcemia in a patient treated for hypoparathyroidism with calcitriol.
    De Sanctis V; Fiscina B; Ciccone S
    Pediatr Endocrinol Rev; 2010 Jun; 7(4):363-5. PubMed ID: 20679997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of adult-onset primary hypoparathyroidism: a retrospective analysis of 200 cases].
    Quan TT; Li YP; Wang O; Jiang Y; Xia WB; Li M; Cheng XQ; Meng XW; Xing XP
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):19-23. PubMed ID: 28056318
    [No Abstract]   [Full Text] [Related]  

  • 8. MANAGEMENT OF ENDOCRINE DISEASE: Hypoparathyroidism in pregnancy: review and evidence-based recommendations for management.
    Khan AA; Clarke B; Rejnmark L; Brandi ML
    Eur J Endocrinol; 2019 Feb; 180(2):R37-R44. PubMed ID: 30444723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
    Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation.
    Caplan RH; Beguin EA
    Obstet Gynecol; 1990 Sep; 76(3 Pt 2):485-9. PubMed ID: 2381632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D toxicity after dieting in hypoparathyroidism.
    Connors MH; Sheikholislam BM; Irias JJ
    Pediatrics; 1976 May; 57(5):794-6. PubMed ID: 1084987
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium and phosphate metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: effects of 1,25-dihydroxyvitamin D3.
    Chan JC; Young RB; Hartenberg MA; Chinchilli VM
    J Pediatr; 1985 Mar; 106(3):421-6. PubMed ID: 3838346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with PTH 1-34 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27 years at a single tertiary care center.
    Winer KK; Ye S; Ferré EMN; Schmitt MM; Zhang B; Cutler GB; Lionakis MS
    Bone; 2021 Aug; 149():115977. PubMed ID: 33932619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative hypoparathyroidism. Hazards from vitamin D therapy.
    Fåhraeus B; Andersson L; Bergdahl L; Westling P
    Acta Chir Scand; 1973; 139(5):437-41. PubMed ID: 4542958
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to Letter: "Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol".
    Streeten EA
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3568. PubMed ID: 28911162
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to the Editor: "Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol".
    Tournis S
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3567. PubMed ID: 28911157
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrocalcinosis, Renal Dysfunction, and Calculi in Patients With Primary Hypoparathyroidism on Long-Term Conventional Therapy.
    Saha S; Kandasamy D; Sharma R; Bal C; Sreenivas V; Goswami R
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31901096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calciferol requirements of patients with surgical hypoparathyroidism.
    Ireland AW; Clubb JS; Neale FC; Posen S; Reeve TS
    Ann Intern Med; 1968 Jul; 69(1):81-9. PubMed ID: 5301642
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
    Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.